Cardiocomm Solutions Stock EBITDA
| EKGGF Stock | USD 0.01 0.00 0.00% |
CardioComm Solutions fundamentals help investors to digest information that contributes to CardioComm Solutions' financial success or failures. It also enables traders to predict the movement of CardioComm Pink Sheet. The fundamental analysis module provides a way to measure CardioComm Solutions' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CardioComm Solutions pink sheet.
CardioComm |
CardioComm Solutions Company EBITDA Analysis
CardioComm Solutions' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current CardioComm Solutions EBITDA | 61.24 K |
Most of CardioComm Solutions' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CardioComm Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, CardioComm Solutions reported earnings before interest,tax, depreciation and amortization of 61.24 K. This is 99.99% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 100.0% higher than that of the company.
CardioComm EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CardioComm Solutions' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CardioComm Solutions could also be used in its relative valuation, which is a method of valuing CardioComm Solutions by comparing valuation metrics of similar companies.CardioComm Solutions is currently under evaluation in ebitda category among its peers.
CardioComm Fundamentals
| Return On Asset | 0.16 | |||
| Profit Margin | 0.28 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 1.82 M | |||
| Shares Outstanding | 151.16 M | |||
| Shares Owned By Insiders | 37.74 % | |||
| Price To Sales | 1.62 X | |||
| Revenue | 682.51 K | |||
| Gross Profit | 734.6 K | |||
| EBITDA | 61.24 K | |||
| Net Income | 283 | |||
| Cash And Equivalents | 153.45 K | |||
| Total Debt | 413.81 K | |||
| Debt To Equity | 430.30 % | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (120.8 K) | |||
| Number Of Employees | 16 | |||
| Beta | -0.25 | |||
| Market Capitalization | 1.69 M | |||
| Total Asset | 486.47 K | |||
| Z Score | 3.4 | |||
| Net Asset | 486.47 K |
About CardioComm Solutions Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CardioComm Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CardioComm Solutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CardioComm Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CardioComm Pink Sheet
CardioComm Solutions financial ratios help investors to determine whether CardioComm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CardioComm with respect to the benefits of owning CardioComm Solutions security.